Employing Tools in Clinical Practice to Accelerate Prompt, Accurate Diagnosis and Risk Assessment in MDS
Employing Tools in Clinical Practice to Accelerate Prompt, Accurate Diagnosis and Risk Assessment in MDS is organized by Prime Education, LLC.
Release Date: May 24, 2023
Expiration Date: May 23, 2024
Description:
Myelodysplastic syndromes (MDS) are both misdiagnosed and underdiagnosed, with evolving diagnostic criteria and risk classification schemas emphasizing the importance of a patient's cytogenetic and molecular profile complicating clinical workflows.
Make sure you download the 5 clinical tools, and then join us in this MDS-expert instructional video for guidance on the seamless integration of these practical resources into clinical practice to improve MDS diagnosis and management. With access to an MDS evaluation checklist, cytogenetic and molecular considerations, and risk assessment guides, transform your practice to allow for evidence-based, personalized treatment decision-making.
This activity is delivered in partnership with the Association for Molecular Pathology (AMP).
Agenda:
• MDS Diagnosis and Evaluation
• Risk Assessment and Prognostication in MDS
• Safety and Efficacy of New and Emerging Therapies in MDS
Learning Objectives:
• Assess best practices for obtaining an accurate MDS diagnosis, including molecular and cytogenetic testing and interpretation
• Distinguish patient- and disease-related factors that affect risk stratification in MDS
• Evaluate recent clinical data on the safety and efficacy of novel therapies for MDS.